Core Viewpoint - The stock of Beishimei experienced a decline of 2.02% on August 27, with a trading price of 11.17 yuan per share and a total market capitalization of 4.034 billion yuan, indicating a mixed performance in recent trading sessions [1]. Financial Performance - For the first half of 2025, Beishimei achieved operating revenue of 776 million yuan, representing a year-on-year growth of 16.57%. The net profit attributable to shareholders was 34.706 million yuan, showing a significant increase of 109.70% compared to the previous period [2]. - Since its A-share listing, Beishimei has distributed a total of 62.87 million yuan in dividends, with 38.52 million yuan distributed over the past three years [3]. Stock Market Activity - As of August 27, Beishimei's stock price has increased by 9.40% year-to-date, but it has seen a decline of 6.92% over the last five trading days. In the last 20 days, the stock rose by 3.71%, and in the last 60 days, it increased by 3.81% [1]. - The stock's trading volume on August 27 was 131 million yuan, with a turnover rate of 3.20%. The net outflow of main funds was 16.33 million yuan, with significant selling pressure observed [1]. Company Overview - Beishimei, established on March 31, 2003, and listed on November 15, 2019, is located in Shaoxing, Zhejiang Province. The company specializes in the research, production, and sales of various chemical products, primarily focusing on 4-nitro intermediates, dimethenamid-p active ingredients, and formulations [1]. - The revenue composition of Beishimei includes 25.95% from dimethenamid-p active ingredients, 25.54% from trade herbicides, 18.91% from trade insecticides, and other chemical products [1]. Shareholder Information - As of June 30, Beishimei had 19,900 shareholders, an increase of 82.96% from the previous period. The average number of tradable shares per shareholder decreased by 45.34% to 18,160 shares [2].
贝斯美跌2.02%,成交额1.31亿元,主力资金净流出1633.18万元